SCHEMBL7910119

SCHEMBL7910119

CCCNC1CC(C)(C)Oc2ccc(OCCOC)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 5/20 0.38
BACE1 P56817 5/20 0.38
KCNE1 P15382 2/20 0.38
KCNQ1 P51787 2/20 0.38
HRH3 Q9Y5N1 1/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HTT P42858 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
PTPN1 P18031 4/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SIRT2 Q8IXJ6 2/20 0.35
BACE2 Q9Y5Z0 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7910107 0.82 SIRT2 (0.43) CTSDBACE1KCNE1KCNQ1MAPT
SCHEMBL7464900 0.76 KCNE1 (0.52) CTSDBACE1KCNE1KCNQ1ALDH1A1
SCHEMBL7900352 0.74 CTSD (0.38) CTSDBACE1KCNE1KCNQ1HRH3
SCHEMBL6600843 0.74 KCNE1 (0.43) KCNE1KCNQ1HRH3MAPTALDH1A1
SCHEMBL7470852 0.72 KCNE1 (0.47) KCNE1KCNQ1MAPTALDH1A1HTT
SCHEMBL7908101 0.72 ALDH1A1 (0.45) KCNE1KCNQ1MAPTALDH1A1HTT
SCHEMBL7910522 0.72 KCNE1 (0.43) CTSDBACE1KCNE1KCNQ1HRH3
SCHEMBL7910113 0.71 ALDH1A1 (0.37) KCNE1KCNQ1HRH3MAPTALDH1A1
SCHEMBL7900347 0.69 ALDH1A1 (0.39) CTSDBACE1KCNE1KCNQ1MAPT
SCHEMBL6559382 0.69 MAPT (0.45) CTSDBACE1KCNE1KCNQ1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177449-B1 CARDIOVASCULAR DISORDERS; ANTIULCER AGENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-01-23 US disclosed